new weight loss drug semaglutide Wegovy Can Also Reduce Risk of Heart Events Half of people stop taking

Rather than administering the full dose immediately, patients begin with a lower weekly dose and gradually increase it over four weeks, allowing their body to adapt and reducing gastrointestinal side effects

It is because adding supplemental ingredients allows compounders to argue their product is not a copy of the FDA-approved drug, which creates a legal pathway to continue compounding

The side effects of these drugs are not fully known, particularly longer-term ones, another reason payers may delay their decision-making process as regards to the current weight-loss drugs, Rayburg said

doi: 10.1007/s00125-004-1379-6 [DOI] [PubMed] [Google Scholar] 40

References Kruchi, K., Cajochen, C., Pache, M., Flammer, J., & WirzJustice, A

Participants will be randomized into an intervention arm of individuals who will receive tirzepatide or a control arm of those who will receive a placebo